Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study
NCT07188220 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2025-09-23
Summary
The aim of this qualitative study is to explore and identify the expectations, perceptions, attitudes, needs, and knowledge related to the management of metabolic dysfunction-associated steatohepatitis (MASH) in patients diagnosed with this condition, before and after their participation in the MASH-Cardiovascular Programme at Hospital de la Santa Creu i Sant Pau, Barcelona.
The main research question is:
What expectations, attitudes, needs, and perceptions do patients with MASH participating in the MASH-Cardiovascular Programme exhibit before and after the intervention?
Participants will undergo two semi-structured interviews: one prior to, and one following, their involvement in the MASH-Cardiovascular Programme at Hospital de Sant Pau i la Santa Creu, Barcelona.
Conditions
- Metabolic Dysfunction Associated Steatohepatitis (MASH)
Sponsors & Collaborators
-
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-03
- Primary Completion
- 2027-12-20
- Completion
- 2028-01-20
Countries
- Spain
Study Locations
More Related Trials
-
Advanced Fibrosis Detection for MASLD in Primary Care
NCT07159386 ·Status: RECRUITING ·Phase: NA
-
Non Alcoholic Fatty Liver Disease Influence of Statin Therapy
NCT00375349 ·Status: WITHDRAWN ·Phase: NA
-
Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD
NCT07313007 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)
NCT07013916 ·Status: RECRUITING ·Phase: NA
-
Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
NCT01987310 ·Status: WITHDRAWN ·Phase: NA
-
Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey
NCT05765890 ·Status: COMPLETED
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
NCT06138821 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD
NCT07194863 ·Status: NOT_YET_RECRUITING
-
DEFINITION OF THE GENOMIC LANDSCAPE OF MASLD
NCT07249112 ·Status: RECRUITING ·Phase: NA
-
Fibrosis Lessens After Metabolic Surgery
NCT06374875 ·Status: RECRUITING ·Phase: PHASE4
-
Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
NCT07205471 ·Status: RECRUITING ·Phase: NA
-
Global Research Initiative for Patients Screening on MASH
NCT05651724 ·Status: RECRUITING
-
Manual Therapy in Metabolic Liver Disease
NCT06338618 ·Status: COMPLETED ·Phase: NA
-
The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
NCT06913699 ·Status: ACTIVE_NOT_RECRUITING
-
The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects
NCT06044467 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis
NCT05065593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effects of Dihydromiricetin on MASLD
NCT05052515 ·Status: COMPLETED ·Phase: NA
-
A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database
NCT06741111 ·Status: COMPLETED
-
Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease
NCT04132440 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study
NCT06078722 ·Status: UNKNOWN
-
Lifestyle Habits and Metabolic Dysfunction-Associated Steatotic Liver Disease in Youth
NCT07095010 ·Status: COMPLETED
-
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
NCT07288138 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment of Non Alcoholic Fatty Liver Disease With Lifestyle Modification and Acupuncture
NCT02006329 ·Status: UNKNOWN ·Phase: NA
-
A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
NCT05395481 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
NCT07221227 ·Status: RECRUITING ·Phase: PHASE3